CLEVELAND -- University Hospitals Case Medical Center's Harrington Discovery Institute announced a grant competition that serves a nationwide search for physician-scientists seeking support to accelerate their promising drug discoveries into novel treatments for patients.
Lacking government and investor funding and partnerships with pharmaceutical companies, many researchers have drug discoveries that are unable to advance into clinical development.
Aimed at addressing this critical issue, the UH Harrington Discovery Institute, launched in February, is the not-for-profit academic medical engine of The Harrington Discovery and Development Project: a first-of-its-kind, $250 million initiative that also includes a mission-aligned, for-profit development company. Aligning these entities for the first time at an academic medical center provides a comprehensive model to advance discoveries into development and create novel drugs and therapies for patient care.
"This is an important step forward for our exciting initiative, which is to create a new model for drug discovery and development in academia," says the Institute's Director, Jonathan Stamler, MD.
The annual grant competition, run by UH Harrington Discovery Institute, will offer to support the translation of research from laboratory to early development stages. Up to ten physician-scientists each year will be supported with Harrington Scholar-Innovator grants of up to $200,000 over two years.
The grant application is open to physician-scientists at accredited academic medical centers, research institutions, and universities in the United States.
Applicants must have a doctorate in medicine, and must demonstrate exceptional promise as physician-scientists. The grant will recognize the importance of innovation to the mission of the physician-scientist.
Applications found HERE are due by 5 p.m. ET, August 1, 2012, and recipients will be announced in the spring of 2013 at the UH Harrington Discovery Institute's inaugural scientific symposium.